HMM201 - Medical Nanotechnology
Unit details
| Year: | 2022 unit information |
|---|---|
| Important Update: | Unit delivery will be in line with the most current COVIDSafe health guidelines. We continue to tailor learning experiences for each unit to achieve the best possible mix of online and on-campus activities that successfully blend our approaches to learning, working and research. Please check your unit sites for announcements and updates. Last updated: 4 March 2022 |
| Enrolment modes: | Trimester 1: Burwood (Melbourne), Waurn Ponds (Geelong) |
| Credit point(s): | 1 |
| EFTSL value: | 0.125 |
| Unit Chair: | Trimester 1: Amardeep Dhillon |
| Prerequisite: | HMM102 or HMM103 |
| Corequisite: | Nil |
| Incompatible with: | Nil |
| Typical study commitment: | Students will on average spend 150 hours over the teaching period undertaking the teaching, learning and assessment activities for this unit. |
| Scheduled learning activities - campus: | Campus: 2 face-to-face contact hours per week (1 x 1 hour class + 1 x 1 hour seminar). The class and seminar will be recorded and placed online at the end of the seminar. Cloud (online): 2 x 1 hour class (recordings provided) |
Content
This unit aims to provide students with a comprehensive understanding of the role that nanotechnology will play in the diagnosis and treatment of medical conditions in the future. This unit will look at how this rapidly developing field will impact human health and the challenges involved.
| ULO | These are the Learning Outcomes (ULO) for this unit. At the completion of this unit, successful students can: | Deakin Graduate Learning Outcomes |
|---|---|---|
| ULO1 | Identify key components in medical nanotechnology and their functions in diagnostics and therapeutics. | GLO1: Discipline-specific knowledge and capabilities |
| ULO2 | Show proficiency in critical analysis of the scale, cost and analytical techniques involved in the production of nanomaterials and the outcome of health care. | GLO1: Discipline-specific knowledge and capabilities |
| ULO3 | Critically evaluate current capabilities of medical nanotechnology and develop judgement to appreciate the complex ethical issues associated with the advancement of nanotechnology. | GLO1: Discipline-specific knowledge and capabilities |
| ULO4 | Design a novel nano-sized device and provide an implementation plan on how it can be applied clinically to improve health care. | GLO4: Critical thinking |
| ULO5 | Critically evaluate how medical nanomaterials are utilised for drug delivery and theranostics. | GLO1: Discipline-specific knowledge and capabilities |
| ULO6 | Make informed decisions about applications of nanotechnologies and the associated potential risk in future medicine. | GLO4: Critical thinking |
Assessment
Trimester 1:| Assessment description | Student output | Grading and weighting (% total mark for unit) | Indicative due week |
|---|---|---|---|
| Assessment 1: Mid-trimester test | 45 minutes | 30% |
|
| Assessment 2: Research Report | Written research report (800 word limit) | 20% |
|
| Assessment 3: Quiz | 4-6 questions relating to lecture content from previous week | 10% |
|
| Assessment 3: Examination | 2 hours - MCQ and short answer questions | 40% |
|
The assessment due weeks provided may change. The Unit Chair will clarify the exact assessment requirements, including the due date, at the start of the teaching period.
Learning Resource
There is no prescribed text. Unit materials are provided via the unit site. This includes unit topic readings and references to further information.
Unit Fee Information
Click on the fee link below which describes you: